One prominent eect of IFNs is their cell growth inhibitory activity. The exact molecular mechanism behind this inhibition of proliferation remains to be elucidated. Possible eectors for IFN-induced growth inhibition are the recently discovered cyclin-dependent kinase inhibitors. The eect of IFN-a treatment on the members of the Ink4 and Cip/Kip families of Cdk inhibitors was investigated in three hematopoietic cell lines Daudi, U-266 and H9. Two of these cell lines, Daudi and U-266, respond to IFN-a by G 1 arrest, whereas the H9 cell line is not growth arrested by IFN-a. We show that a p53-independent upregulation of p21 mRNA occurs following IFN-a treatment in all three cell lines. In Daudi and U-266 cells, the mRNA induction is accompanied by an increase in p21 protein, followed by an increased binding of p21 to Cdk2 and a subsequent decrease in Cdk2 activity, temporally coinciding with G 1 arrest. In both these cell lines, there was also an increased binding of p21 to Cdk4. In contrast, p21 protein was not expressed in H9 cells, despite high levels of p21 mRNA following IFN-a treatment. In U-266 cells, IFN-a increased not only p21 but also p15 mRNA and protein levels, followed by an increased association of p15 with Cdk4. Furthermore, IFN-a treatment caused a four-to sixfold induction of the p16 E1b transcript in U-266 cells. Expression levels of the other Ink4 and Cip/ Kip Cdk inhibitors were not induced by IFN treatment in any of the cell lines. We conclude that IFN-a can act as a potent regulator of Cdk-inhibitor expression, correlating with decreased Cdk activity and cell growth inhibition. One mechanism for resistance to IFN may be loss of the ability of cells to upregulate these proteins.
Introduction
The interferons (IFNs) are a family of proteins which are produced by eukaryotic cells when challenged by viruses and other agents. Following binding to speci®c cell surface receptors, IFNs induce transcription of IFN-stimulated genes through activation of the Jak/ STAT signaling pathway (Shuai, 1994) , whereby IFNs elicit a number of physiological responses in cells, with the common denominator of inhibiting viral replication (reviewed in De Mayer and De Mayer-Guiginard, 1988) . It was shown in the early 60s that IFNs also exert cell growth inhibitory eects. It has since been found that this antiproliferative action of IFNs can be observed in many cell types from established cell lines, normal tissues and primary tumor cells (TaylorPapadimitriou and Rozengurt, 1985) . It has been postulated that this eect may, at least in part, mediate the antitumor eects observed in some malignancies (Brenning et al., 1985) . In vitro culture of susceptible cell types with IFN commonly leads to G 1 arrest, but sometimes to a lengthening of S-phase or all phases of the cell cycle (Roos et al., 1984) .
With the discovery of the proteins that normally regulate the cell cycle, some of the molecular eectors responsible for the IFN induced cell growth inhibition have been identi®ed. A number of proteins already identi®ed as key regulators of the cell cycle such as pRb, cyclin A, E2F, Cdk2 and c-myc are downstream targets in IFNs growth suppressive action (Kimchi, 1992; Melamed et al., 1993; Zhang and Kumar, 1994) . However, the exact chain of events responsible for the antiproliferative eect of IFN is still unclear.
During the last few years a host of knowledge has been gained in the ®eld of cell cycle regulation. In all organisms studied so far, passage through the cell cycle is dependent on the sequential formation and activation of complexes consisting of cyclin dependent kinases (Cdks) and their cyclin partners. In mammalian cells the complexes active in G 1 contain cyclin D-Cdk4/6 and cyclin E-Cdk2 (reviewed in GranÄ a and Reddy, 1995) . Many proteins have been suggested as targets of dierent cyclin/Cdk complexes (Nigg, 1993) . One of the most studied substrates is the Rb protein, which upon phosphorylation enables the E2F transcription factor to activate genes necessary for S phase progression (Nevins, 1994) . The activity of Cdk complexes have also been shown to be regulated by phosphorylation and dephosphorylation on speci®c residues (Morgan, 1995) . Recently a new level of regulation of these complexes has been elucidated by the indenti®cation of low molecular weight cyclin dependent kinase inhibitors (Sherr and Roberts, 1995) . In the mammalian system, two families of Cdkinhibitors have been identi®ed. The Ink4 family includes the p15, p16, p18 and p19 proteins, which all contain several ankyrin repeat like sequences. These inhibitors bind speci®cally to Cdk4 and 6, thereby interfering with cyclin D binding to the kinases. The p16 gene is commonly mutated or deleted in human malignancies (Kamb et al., 1994; Nobori et al., 1994) . Recently, an alternative ®rst exon (E1b) of the p16 gene has been described. When the E1b exon is spliced onto exon 2 of the p16 gene, the original reading frame is shifted, and translation of this so called b transcript creates a protein completely unrelated to p16. Interestingly this protein seems to have cell growth inhibitory properties, although it has not been shown to be a direct Cdk-inhibitor (Quelle et al., 1995) .
The Cip/Kip family include the sequence, p21, p27 and p57 proteins, which share no homology with the Ink4 family (Sherr and Roberts, 1995) . The latter group of Cdk-inhibitors associate with and inhibit the cyclin E-Cdk2 and cyclin A-Cdk2 complexes, in addition to inhibiting cyclin D-Cdk4 and 6 complexes. The p21 gene is transcriptionally regulated by the p53 tumor suppressor gene, thereby mediating cell cycle arrest. However, p53 independent induction of p21 has recently been described (El-Deiry et al., 1993; Elbendary et al., 1994; Datto et al., 1995; Parker et al., 1995; ReynisdoÂ ttir et al., 1995) . In addition to associating with dierent cyclin/Cdk complexes, the p21 protein (but not p27 or p57) can bind to proliferating cell nuclear antigen (PCNA), and inhibit DNA replication (Waga et al., 1994) . However this activity maps to a dierent region of the p21 protein than the one interacting with cyclin/Cdk complexes (Chen et al., 1995) . Moreover, p21 has also been shown to disrupt the interaction between Cdk2 and the E2F-p107/p130 complexes (Zhu et al., 1995; Shianov et al., 1995) .
A few previous observations prompted our interest in examining whether Cdk-inhibitors may be targets for regulation by IFNs. Firstly, other extracellular signals for growth arrest such as TGF-b, contact inhibition and serum starvation have been shown to act, at least in part, through the modulation of Cdkinhibitors. TGF-b induces p15 and p21 at the transcriptional level. It also increases the amount of p27 bound to Cdk2, and reduces Cdk4 levels (Elbendary et al., 1994; Hannon and Beach, 1994; Polyak et al., 1994; Datto et al., 1995 ., ReynisdoÂ ttir et al., 1995 . Other growth inhibitory cytokines may conceivably work in a similar fashion. Secondly, the previously described eects on cell cycle regulating proteins by IFN, such as reduced pRb phosphorylation and the inhibition of Cdk2 kinase activity are all compatible with an induction of Cdk-inhibitor activity. We have therefore analysed the eects of IFN-a on the expression of the Ink4-and Cip/Kip-families of Cdkinhibitors in three hematopoietic cell lines.
Results
As IFN under physiological circumstances is likely to act by arresting actively proliferating cells, we investigated the eects of IFN-a treatment of proliferating cell cultures, rather than on cells released from quiescence.
IFN-a eects on cell cycle progression in Daudi, U-266 and H9 cells
The integrity of the IFN signal transduction pathway was shown by demonstrating that all three cell lines were sensitive to IFN-a, as measured by induction of the IFN stimulated gene, 2', 5' oligoadenylate synthetase. A 11 ± 40-fold induction of enzyme activity was detected after incubation with 5000 U/ml of IFN-a for 24 h.
The eect of IFN-a on cell cycle distribution and DNA synthesis was examined by¯ow cytometry and (Figure 1 ). In contrast, no change in cell cycle distribution was observed in H9 cells after IFN-a treatment (Figure 1 ). Both U-266 and H9 cells were found to undergo apoptosis following longer times of exposure to IFN-a (Sangfelt et al., submitted) .
Since the Rb protein is implicated in the control of G 1 progression and has previously been shown to be an important target for IFN's cell growth inhibitory action, we examined the status and eects of IFN-a treatment on this protein in the three cell lines. In cycling Daudi cells the major portion of the Rb protein appeared as slowly-migrating hyperphosphorylated . After exposure to IFN-a, a progressive conversion to the fast-migrating underphosphorylated forms occurred around 8 ± 12 h after addition of IFN-a (Figure 2 ). No Rb protein was expressed in U-266 cells (data not shown), possibly due to a genomic deletion within the pRb gene previously described in this cell line (Corradini et al., 1994) . Thus, the observed G 1 arrest in U-266 cells after IFN-a treatment is not dependent on functional Rb protein. Likewise, there was no expression of Rb protein in H9 cells (data not shown).
IFN-a eects on the expression of Ink4 inhibitory proteins
The eects of IFN-a on the expression of the dierent members of the Ink4 family of Cdk inhibitors were examined in all three cell lines. The IFN-a arrested cell line U-266 expressed two p15 mRNA transcripts (2.2 and 3.2 kb). IFN-a treatment of these cells resulted in a 4 ± 6-fold induction of both transcripts, reaching a maximum at 8 h after the addition of IFN-a (Figure 3 ). The observed increase in p15 mRNA, was paralleled by increase in p15 protein expression, which was detected as a double band in this cell line (data not shown). In contrast, no p15 mRNA or protein expression could be detected in cycling Daudi cells and IFN-a treatment did not induce the expression of p15 in these cells (data not shown). H9 cells were not examined for p15 or p16 expression, as this cell line carries a homozygous deletion of 9p21 sequences including these genes (Borgonovo Brandter et al., 1996) . We further examined the expression of p16 in U-266 and Daudi cells. In none of these cell lines, could expression of the p16 E1a mRNA or p16 protein be detected (data not shown). Interestingly, there was an approximate ®vefold induction of the p16 E1b transcript in U-266 cells, reaching maximum levels at 12 h after IFN-a addition ( Figure 3 ). In contrast, although weakly expressed at all time points, the E1b mRNA level was not aected by IFN-a treatment in Daudi cells (Figure 3 ).
The expression of the newly identi®ed p16 homologue p18 was also examined. All three cell lines expressed two p18 mRNA transcripts (1.9 and 2.5 kb). In IFN-a treated Daudi cells, the ratio was changed between the two transcripts. A decrease in the larger transcript was paralleled by an increase in the expression of the smaller transcript at around 9 to 12 h of IFN-a treatment ( Figure 4 ). Repeated experiments also showed that this shift in transcript ratio was accompanied by a transient decrease in p18 protein expression levels in Daudi cells ( Figure 4 ). In U-266 and H9 cells, addition of IFN-a did not change the p18 mRNA or protein expression (data not shown).
We further examined the expression and responsiveness to IFN-a of the p19 Cdk-inhibitor. All cell lines expressed the 1.3 kb p19 transcript and IFN-a treatment did not aect the expression level of this Cdk-inhibitor (data not shown). 
IFN-a eects on the expression of Cip/Kip inhibitory proteins
Expression levels of the Cip/Kip inhibitory proteins were examined in all three cell lines. A rapid induction of p21 mRNA expression was observed subsequent to IFN-a treatment in all three cell lines ( Figure 5 ). Compared to U-266 and H9 cells, Daudi cells showed a weaker induction of p21 mRNA (three times), but seem to express the highest baseline levels of p21 mRNA ( Figure 5 ). U-266 cells expressed moderate levels of p21 mRNA, IFN-a treatment of these cells increased p21 mRNA expression levels more than eight times ( Figure 5 ). In H9 cells the p21 message was barely detectable in the absence of IFN-a, but was highly induced (25-fold) in response to IFN-a treatment ( Figure 5 ). In all three cell lines, p21 induction was obvious already 1 ± 2 h after addition of IFN-a, with highest expression occuring around 12 h of IFN-a treatment ( Figure 5 ). In U-266 and Daudi cells, which are both G 1 arrested by IFN-a, the rise in p21 mRNA levels was paralleled by an increase in p21 protein (Figure 6 ). Interestingly, despite the observed induction of p21 mRNA in H9 cells, which are not growth arrested by IFN-a, there was a complete lack of p21 protein expression in these cells, even in the presence of IFN-a (Figure 6 ).
Since the p21 gene has shown to be positively transcriptionally regulated by the tumor suppressor protein p53, we examined whether the observed IFN-a associated p21 induction was dependent on wild type p53. Immunostaining analysis was performed for wild type and mutant p53 expression. Daudi, U-266 as well as H9 cells stained strongly with the monoclonal antibody pAb 240 that recognizes mutant p53 protein only, whereas all three cell lines were negative with the antibody pAb 1620 that recognizes wild-type p53 protein alone (data not shown). Thus, all three cell lines express mutant p53 protein, consistent with previously reported results in these cell lines (Cheng 
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F igure 6 Eects of IFN-a (5000 U/ml) on the steady state protein levels of p21 as determined by Western blot analysis. Exponentially growing cells were treated with IFN-a (5000 U/ml) for the indicated times (a). Quantitation of p21 protein levels in U-266 and Daudi cells at the indicated timepoints (b). Values represent the relative induction of p21 as normalized to p21 protein expression levels in untreated cells (timepoint 0). As a control for equal loading and transfer, membranes were stained with Ponceau red (Sigma) and Haas, 1990; Mazars et al., 1990; Wiman et al., 1991) , suggesting that the p21 induction was not p53 dependent.
We further examined the expression and responsiveness to IFN-a of the p27 and p57 Cdk-inhibitors. As measured by Western blotting, the p27 protein was expressed in U-266 and Daudi cells. However, IFN-a treatment did not alter the expression of p27 in these cells (data not shown), In constrast, no p27 expression could be detected in H9 cells. p57 mRNA expression could not be detected in any of the three cell lines (data not shown).
Changes in binding of Cdk-inhibitors to Cdk2 and Cdk4 and alterations in Cdk2 activity following IFN-a treatment
The cell lines were examined for the expression of mRNA and protein for Cdk2, 4 and 6. Cdk2 and Cdk4 mRNA and protein was expressed at similar levels in all three cell lines (data not shown). Only U-266 cells expressed signi®cant levels of Cdk6 mRNA (data not shown). IFN-a treatment had no eect on mRNA or proteins levels of any of these Cdks (data not shown). In both U-266 and Daudi cells, the increase in p21 protein expression was followed by an increase in the amount of p21 bound to Cdk2, as analysed by immunoprecipitation of Cdk2 complexes followed by Western blotting with p21 antibodies (Figure 7) . Furthermore, immunoprecipitated Cdk2 complexes were analysed for kinase activity using histone H1 as substrate. There was 60 ± 70% decrease in Cdk2 phosphorylating activity in IFN-a treated U-266 and Daudi cells after 16 ± 24 h of treatment (Figure 7) . Similarly, we also observed an increased binding of p21 to Cdk4 following IFN-a treatment in both U-266 and Daudi cells (Figure 8) . Additionally, the observed IFN-a induced increase in p15 expression levels in U-266 cells, was followed by an increase in the amount of p15 bound to Cdk4 (Figure 8 ). Also after immunoprecipitation, p15 protein was detected as a double band (15 kD and 17 kD). Since U-226 cells do not express the p16 protein (examined using two dierent p16 antiobodies), the upper band is not due to crosshybridization to p16. Neither was it due to crosshybridization with p18 protein, as p18 is detected at a dierent position (data not shown).
Discussion
Extracellular signals are important in the regulation of cellular proliferation. A large number of growth factors have been found to date. In contrast only a small number of cytokines which induce cell growth inhibition have been described. Among the latter are the TGF-b and IFN families of proteins (TaylorPapadimitriou and Rozengurt, 1985; MassagueÂ , 1990) . The recent elucidation of how the cell cycle is regulated, including the realization of the importance of cyclin-Cdk complexes and their newly discovered inhibitors, has made it possible to study the eects of growth inhibitory cytokines on these proteins. TGF-b has been found to upregulate the activity of at least three Cdk-inhibitors, p15, p21 and p27, in addition to decreasing the expression of Cdk4 (Elbendary et al., 1994; Hannon and Beach, 1994; Polyak et al., 1994; Datto et al., 1995; ReynisdoÂ ttir et al., 1995) . The results from these studies also indicate that the eect of TGF-b on cell cycle regulating proteins can be cell type speci®c . Other extracellular growth inhibitory signals, such as contact inhibition and cAMP induced cell cycle arrest, have also been shown to be associated with an increased expression of Cdk-inhibitors Polyak et al., 1994) .
Less is known about the mechanism behind the antiproliferative action of IFN. Such knowledge seems especially warranted, since IFNs are widely used in the treatment of malignant disease, with the antiproliferative eect as one possible eector mechanism. IFNs have been shown, in analogy with TGF-b, to prevent the phosphorylation of pRb, decrease E2F DNA binding activity, reduce c-myc and cyclin A levels, as well as to decrease the activity of Cdk2 complexes (Kimchi, 1992; Melamed et al., 1993, Zhang and Kumar, 1994) . One mechanism behind alterations in the above mentioned proteins could be an eect of IFN on Cdk-inhibitory proteins.
In the present study we therefore examined the eects of IFN-a on the expression of Cdk-inhibitors, as well as Cdk2, 4 and 6, in three hematopoietic cell lines. Two of the cell lines, Daudi and U-266, respond to IFN-a by a G 1 growth arrest, whereas the H9 cell line is not growth arrested by IFN-a. Our results demonstrate that IFN-a causes a rapid induction of mRNA for the p21 Cdk inhibitor in all three cell lines. In the G 1 arrested cell lines, Daudi and U-266, this is followed by an increase in p21 protein levels. Analysis of Cdk4 and Cdk2 complexes showed a strong increase in the amount of p21 bound, and a subsequent decrease in kinase activity of Cdk2 in IFN-a treated cells, coinciding with G 1 arrest in these cell lines. Interestingly, in H9 cells, which are not growth arrested by IFN-a, there is a complete lack of p21 protein expression in spite of a 25-fold increase in p21 mRNA levels. The reason for the lack of p21 protein expression is unknown. It is possible that this cell line carries an intragenic mutation in the p21 gene, leading to inhibition of translation or a truncated protein that is not detected by the monoclonal antibody used in these studies. The lack of p21 protein expression may theoretically be the reason for the lack of cell growth arrest by IFN-a in cells as discussed below.
The fact that the induction of p21 occurs within 1 ± 2 h after addition of IFN-a, preceding G 1 arrest, indicates that the eect on p21 expression is not secondary to IFN-a induced cell growth inhibition. This conclusion is also supported by the ®nding of p21 mRNA induction in H9 cells, which are not growth arrested by IFN-a. Taken together, the results suggest that the rapid increase in p21 after IFN-a treatment may play a causative role in IFN-a mediated growth arrest. It also supports a model in which a single Cdk inhibitor can serve as an eector of diverse signals for cell cycle arrest, including signals from within the cell such as DNA damage, as well as extracellular signalling mediating by TGF-b and IFN-a. The data obtained with these growth inhibitory cytokines are somewhat paradoxical in comparison with the data indicating induction of p21 as an immediate-early gene following mitogenic stimulation. This may be explained by the fact that p21 at low concentrations enhances Cdk complex kinase activity whereas high levels lead to an inhibition of kinase activity Macleod et al., 1995) .
p21 transcriptional activation has previously been reported in response to p53 induction as well as by p53 independent pathways (El-Deiry et al., 1993; Elbendary et al., 1994; Datto et al., 1995 Macleod et al., 1995 Parker et al., 1995) . The potential role of p53 in IFN-a mediated induction of p21 was therefore determined by examination of the p53 status in these cell lines. All three cell lines expressed p53 protein that was detected by antibodies recognizing mutant p53, in accord with previous studies in these cell lines (Cheng and Haas, 1990; Mazars et al., 1990; Wiman et al., 1991) . This suggests that cell growth inhibition by IFN-a is not dependent on the presence of wild type p53 and that IFN-a, similar to TGF-b, can induce p21 in a p53 independent manner. We are currently investigating whether the p21 promotor is directly transcriptionally regulated by IFN-a. The published p21 promotor sequence does not display any obvious interferonstimulated-response-elements (ISREs). IFN-a thus acts either indirectly, through the induction of some other protein(s), alternatively IFN-a induced transcription can be mediated by elements other than the classical ISRE. Interestingly, it has recently been shown that the p21 gene is transcriptionally activated by IFN-g through a STAT1-dependent pathway (Chin et al., 1996) .
Additionally, we observed an induction of p15 mRNA and protein levels rising within a few hours of IFN-a treatment in U-266 cells, whereas no such induction was found in Daudi cells. The observed increase in p15 expression in U-266 cells was followed by an increased binding to Cdk4. Whether this leads to an inhibition of Cdk4/6 activity is currently investigated, as well as whether increased binding of p15 displaces p27 associated with Cdk4/6 making it available for Cdk2 binding. Theoretically this could lead to additional inhibition of Cdk2 activity, as has been suggested in TGF-b induced cell cycle arrest ReynisdoÂ ttir et al., 1995) . The lack of p15 expession and IFN-inducability in Daudi cells could be due to methylation of the p15 gene, as has been found in this and other Burkitt lymphoma cell lines (Herman et al., 1996; and U Klangby Karolinska Institute, personal communication) . In U-266 cells we observed a rapid ®vefold induction of the newly discovered p16 E1b transcript. It has previously been disputed whether this transcript translates into a functional protein, as the original reading frame is shifted when the E1b exon is spliced onto exon 2 of the p16 gene. Recently a translation product has been found in rodent cells and, interestingly, this protein has cell growth inhibitory activity (Quelle et al., 1995) . The ®nding that the expression of this gene can be regulated by IFN-a adds support to the hypothesis that the resulting protein has a function in cellular physiology.
In neither Daudi nor U-266 cells did we observe any expression or induction of p16 E1a transcript. The undetectable p16 expression in U-266 cells is somewhat intriguing since these cells carry a pRb gene mutation (Corradini et al., 1994) , which in other cell lines has been shown to correlate with high levels of p16 protein . pRb has been suggested to be an important downstream eector of IFN induced cell growth inhibition (Kimchi, 1992) . The fact that U-266 cells are blocked in G 1 indicates that the presence of wild type pRb is not mandatory to obtain G 1 arrest by IFN. It can of course not be excluded that other members of the pocket protein family may be active in this cell line, and that the decrease in Cdk2 activity may presumably lead to a decreased phosphorylation of these or other unknown target proteins. Since it has been suggested that p16 and p18 are dependent on functional pRb protein for their action (Kun-Liang et al., 1994; Lukas et al., 1995; Parry et al., 1995) , the data indicate that IFN induced G 1 arrest can occur independently of these Cdk inhibitors.
In addition to the above ®ndings we also observed an IFN-a induced shift in p18 transcripts, accompanied by a slight transient decrease in p18 protein levels in Daudi cells. The signi®cance of this ®nding is unclear, but one possibility may be that this occurs secondary to pRb dephosphorylation, which has been shown to in¯uence the expression of p16 .
The reason for resistance to IFN-a induced growth arrest in the H9 cell line has yet to be determined. It might depend on several factors, such as deletion of the p15 and p16 genes, lack of pRb expression as well as the inability to produce p21 protein. The fact that Daudi cells arrest in the absence of p15/p16 expression/ induction and that U-266 cells are blocked in the absence of functional pRb argues for the lack of p21 protein as the most important candidate for resistance to IFN-a induced cell growth inhibition in the H9 cell line.
In summary, IFN-a regulates the levels of Ink4 and Cip/Kip Cdk-inhibitors in analogy with TGF-b and other extracellular signals for growth arrest. Interestingly, we also observed an induction of the newly described p16 E1b transcript in one of the cell lines. As in the case of TGF-b, the response to IFN-a with regard to Cdk-inhibitors seems to be cell line dependent. A common denominator in the two G 1 arrested cell lines was the induction of p21. This may imply that the increase in p21 levels is causative for the cell growth inhibitory activity of IFN-a. This does, however, not exclude the possible importance of other factors, such as regulation of cyclins, Cdc25 or CAK activity, not investigated in the present study. Another possibility could be that IFN-a alters the amount of p27 bound to Cdk2, as has been described for TGF-b. These issues are currently under investigation. Resistance to IFN induced cell growth inhibition may be due to an inability of cells to induce Cdk-inhibitors, as in the case of H9. Whether similar defects exist in other cell lines not undergoing cell cycle arrest subsequent to IFN treatment, remains to be studied. Since the cell growth inhibitory eect of IFN may play an important role in IFN's clinical antitumor action, a better understanding of the molecular mechanisms behind this activity as well as causes for resistance, may be of help in improving tumor therapy with IFN.
Materials and methods

Cell lines, culture conditions and interferon preparation
Three malignant lymphoid cell lines were used in this study; the H9 cell line, derived from the continuous T-cell lymphoma cell line Hut-78 (Mann, 1989) , the myeloma cell line U-266, kindly provided by Dr Kenneth Nilsson, Uppsala Sweden, and the Burkitt lymphoma (BL) cell line Daudi (ATCC, Rockville, MD).
All cell lines were grown in RPMI (GIBCO, Berlin, Germany) supplemented with 10% heat-inactivated fetal calf serum (Seromed; Biochrom KG, Berlin, Germany), 2 mM glutamine, 50 mg/ml of streptomycin and 50 mg/ml of penicillin and were kept at 378C in a humid incubator with 5% CO 2 . The cell lines were cultured in the presence and absence of IFN-a for up to 48 h. RNA and protein was prepared from cells harvested at dierent time points after addition of IFN-a.
Recombinant human IFN-a 2 b (from Schering-Plough, Kenilworth, NJ) was used for the in vitro experiments. This IFN preparation had a speci®c activity of 2.0610 8 units/mg of protein and the purity was 499%.
DNA labeling and¯ow cytometric analysis
For DNA histograms, cells were ®xed in 4% formaldehyde in phosphate buer during 18 h followed by 95% ethanol treated with subtilisin Carlsberg solution (0.1% Sigma protease XXIV, 0.1 M Tris-HCl, 0.07 M NaCl, pH 7.2) and stained with DAPI-SR101 solution as previously described (Castro et al., 1993) . The samples were analysed using a PAS II¯ow cytometer (Partec, MuÈ nster, BRD), equipped with a 100 W mercury arc lamp HBO 100. DAPĪ uorescence was measured above 435 nm. Flow cytometric data were analysed using Multicycle program (Phoenix Flow Systems, San Diego, CA).
Western blot and immunocytochemistry analysis
Western blot analysis was performed essentially as described (Finke et al., 1987) . Whole cell extracts were prepared by lysis in equal volumes of Nonidet P-40 (NP-40) buer (100 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1.0% NP-40%, 15 mM aprotinin, 50 mM leupeptin, 1 mM phenylmethyl-sulfonyl¯uoride (PMSF), 1 mM sodium vanadate) and 46Laemmli buer (125 mM Tris-HCl, pH 6.8, 4% sodiumdodecyl-sulfate (SDS), 20% glycerol, 200 mM dithiothreitol (DTT)). Protein concentration in cell extracts was quantitated spectrophotometrically with a protein assay kit, according to the instructions of the manufacturer (Bio-Rad, Hercules, CA). Proteins were resolved on a 7% (for Rb protein) or a 13% (for all other proteins) SDS-polyacrylamide gel, electroblotted to membranes (Hybond C-extra, Amersham Life Sciences) by semidry transfer. As a control for equal loading and transfer, membranes were stained with Ponceau red (Sigma). For protein detection, immunoblots were probed with the following monoclonal antibodies; anti-Rb (1:1000), anti-p16 (1:500), anti-p21 (1:500), anti-p27 (1:1000) and the following polyclonal antibodies; anti-p15 (1:50), anti-p16 (1:1000), anti-p18 (1:3000), anti-Cdk2 (1:500) and anti-Cdk4 (1:1000). Antibody-antigen interactions were detected by incubation with horseradishperoxidase-conjugated anti-mouse and anti-rabbit IgG antibodies followed by enhanced chemiluminescence (Amersham, Aylesbury, UK). All antibodies used for Western blot analysis were obtained from PharMingen (San Diego, CA), except for p18 antibodies (kindly provided by Dr Y Xiong, University of North Carolina, Chapel Hill, NC) and p15 antibodies (Santa Cruz Biotechnology, CA). p53 expression in individual cells was analysed in cytospinic preparations, using two dierent monoclonal anti-p53 antibodies, pAb 240 and 1620 (Oncogene Science, Uniondale, NY), as previously described (Sangfelt et al., in press ). The pAb 240 reacts only with mutant human p53. The pAb 1620 reacts with wild type human p53 (although some mutant forms may react).
Cells from a follicular lymphoma patient were used as a negative control for p53 expression. Cells from a BL cell line, BL41, transfected with a temperature sensitive p53 construct (Ramqvist et al., 1993) , were used as controls for mutant and wild type p53 expression. BL41 cells were also used as negative and positive controls for p21 expression in Western analysis. Cells from the H9 cell line and the SaOS-2 osteosarcoma cell lines, were used as negative and positive controls for p16 expression.
Immunoprecipitation and histone H1 kinase assay
For immunoprecipitation cells were harvested at dierent timepoints, washed once with PBS and cell pellets were lysed in LSLD buer (50 mM HEPES at pH 7.4, 50 mM NaC1, 10% Glycerol, 0.1% Tween 20, 0.3 mM Naorthovanadate, 50 mM NaF, 80 mM b-glycerophosphate, 20 mM Na-pyrosphophate, 1 mM DTT and 1 mM PMSF, 10 mg/ml of leupeptin, 10 mg/ml of antipain, 100 mg/ml of benzamidine hydrochloride, 5 mg/ml of aprotinin and 100 mg/ml of soybean trypsin inhibitor). Cell lysates were precleared by incubation with protein A-sepharose over night at 48C, with gentle agitation. Lysates were incubated with anti-Cdk2 or Cdk4 antibodies (kindly provided by Dr D Beach, Cold Spring Harbor; USA) for 1 ± 2 h at 48C. Immunocomplexes were then bound to protein A-Sepharose and washed several times with LSLD buer. Immunoprecipitated proteins were resolved by separation on SDS ± PAGE, electroblotted to ®lters and hybridized with dierent antibodies as described above.
For kinase assay, immunoprecipitation was performed as described above. Immunocomplexes were subsequently washed three times in kinase buer (50 mM Tris-HCl at pH 7.5, 10 mM MgCl 2 and 1 mM DTT). Washed complexes were resuspended in kinase buer and the activity was assayed by addition of 5 mg histone H1 (Sigma), 1 mM ATP and 5 mCi [g-32 P]ATP (5000 Ci/mmole) (Amersham Life Sciences) to a ®nal volume of 50 ml and incubated for 30 min at 308C. The reaction was stopped by addition of one vol 26SDS sample buer and boiling for 5 min. An aliquot of the reaction was loaded on a 13% SDS ± PAGE and separated. The gel was dried and exposed to X-ray ®lm (Amersham Life Sciences).
Northern blot analysis
Total cellular RNA isolation and Northern blot analysis were carried out as previously described using 20 mg of RNA per lane (Heyman et al., 1994) . Northern blot ®lters (Hybond C-extra, Amersham Life Sciences) were hybridized with the following cDNA probes, p21 p16, p18, p19, Cdk2, 4 and 6. A p16E1b speci®c probe was generated by PCR ampli®cation and restriction cleavage of the PCR product. The following primer pair was used: 5'-TCCCAGTCTGCAGTTAAGG-3' and 5'-GTCTAAGT-CGTTGTAACCCG-3'. The resulting product was then cleaved with SacII.
Poly(A) + RNA was isolated using Dynabeads mRNA DIRECT kit (Dynal, Oslo, Norway) according to the protocol provided by the supplier. Poly(A) + RNA ®lters were hybridized with cDNA probes for p15 and p57. The amount of RNA in each sample was normalized by hybridizing the ®lters with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA probe. All probes were labeled by an oligonucleotide labeling kit, using the protocols provided by the supplier (Pharmacia, Uppsala, Sweden).
Quantitation of band intensity
Hybridization signals were quantitated by scanning densitometry using an Ultroscan XL (Pharmacia LKB Biotechnology, Uppsala, Sweden). 2', 5' oligoadenylate synthetase (2', 5'-A) assay
The cytoplasmic levels of 2', 5'-A were determined in NP-40 lysed cells following incubation with poly(rI) poly(rC) agarose beads as previously described (GrandeÂ r et al., 1990) .
